Abstract:A notable shift in understanding the human microbiome's influence on cardiovascular disease (CVD) is underway, although the causal association remains elusive. A systematic review and meta-analysis were conducted to synthesise current knowledge on microbial taxonomy and metabolite variations between healthy controls (HCs) and those with CVD. An extensive search encompassing three databases identified 67 relevant studies (2012–2023) covering CVD pathologies from 4707 reports. Metagenomic and metabolomic data, both qualitative and quantitative, were obtained. Analysis revealed substantial variability in microbial alpha and beta diversities. Moreover, specific changes in bacterial populations were shown, including increased Streptococcus and Proteobacteria and decreased Faecalibacterium in patients with CVD compared with HC. Additionally, elevated trimethylamine N-oxide levels were reported in CVD cases. Biochemical parameter analysis indicated increased fasting glucose and triglycerides and decreased total cholesterol and low- and high-density lipoprotein cholesterol levels in diseased individuals. This study revealed a significant relationship between certain bacterial species and CVD. Additionally, it has become clear that there are substantial inconsistencies in the methodologies employed and the reporting standards adhered to in various studies. Undoubtedly, standardising research methodologies and developing extensive guidelines for microbiome studies are crucial for advancing the field.

What problem does this paper attempt to address?

The paper aims to explore the role of the gut microbiome in cardiovascular disease (CVD) and to synthesize current knowledge on microbial taxonomy and metabolite changes between healthy controls and CVD patients through a systematic review and meta-analysis. Specifically, the researchers hope to reveal the functional role of the gut microbiome in the pathophysiology of cardiovascular disease through this work, thereby promoting the development of innovative therapeutic strategies and advancements in prevention and early detection technologies. The study analyzed 67 published research articles, covering sample data from a total of 4855 control group members and 6090 patients from 2012 to 2023. Major findings include changes in specific bacterial species (such as an increase in Streptococcus and Proteobacteria, and a decrease in Bacteroides), as well as elevated levels of trimethylamine N-oxide (TMAO) in CVD patients. Additionally, the study highlights significant inconsistencies and differences in reporting standards among existing research methods, emphasizing the importance of standardized research methodologies.

Unravelling the Gut Microbiome Role in Cardiovascular Disease: A Systematic Review and a Meta-Analysis